Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
If you do have the symptoms of Covid-19, or are in isolation because you are in a high-risk group, and consequently have to wait for an injection please read the following information: Information for patients whose surgery or health centre has closed or is no longer providing injections due to Covid-19
While in most cases, the drug-induced kidney injury is reversible upon cease of treatment some medications could lead to chronic dysfunction such as papillary necrosis, tubulointerstitial nephritis, or prolonged proteinuria (Choudhury and Ahmed 2006)
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang CH, Tsai WC, Hsu YH, Pang JH, Molecules, 2014 Nov 19;19(11):1906619077
A consultation with a specialist can help assess your suitability for this treatment
Any use for medical wound management, injectables, or post-radiation therapy care falls under pharmaceutical regulation and lies outside the intended scope